Articles
Specialised commissioning continues to be an issue of significance and uncertainty for both the NHS and industry. What do the latest reports of regional push back on the plans for devolution to Integrated Care Boards (ICBs) mean? Learn more about our upcoming webinar here.
For the past 2 years, Pharma, Medtech, and Diagnostic companies have identified the delegation of specialised commissioning to the new Integrated Care Boards (ICBs) as a key risk to their UK market access strategies. With its importance to income and the high risk of change devolution seems to promise, specialised commissioning is an obvious issue for providers of these products to place at the top of their risk logs. The devolution plans are also a risk for the NHS. Not least, because around two-thirds of the income of a…
For the past 2 years, Pharma, Medtech, and Diagnostic companies have identified the delegation of specialised commissioning to the new Integrated Care Boards (ICBs) as a key risk to their UK market access strategies. With its importance to income and the high risk of change devolution seems to promise, specialised commissioning is an obvious issue for providers of these products to place at the top of their risk logs. The devolution plans are also a risk for the NHS. Not least, because around two-thirds of the income of a…
For the preparation of drug delivery vehicle microspheres, microfluidic technology can produce microspheres in one step without further purification, with very homogeneous particle size and good monodispersity, thus microfluidic technology shows outstanding advantages in the preparation of drug delivery vehicles.
Microfluidic technology enables the preparation of microspheres with good monodispersity and controlled particle size and morphology. Carrier microspheres can be used as drug delivery vehicles to modify the drug release efficiency and improve the accuracy of drug action at the target site. For the preparation of drug delivery vehicle microspheres, microfluidic technology can produce microspheres in one step without further purification, with very homogeneous particle size and…
Microfluidic technology enables the preparation of microspheres with good monodispersity and controlled particle size and morphology. Carrier microspheres can be used as drug delivery vehicles to modify the drug release efficiency and improve the accuracy of drug action at the target site. For the preparation of drug delivery vehicle microspheres, microfluidic technology can produce microspheres in one step without further purification, with very homogeneous particle size and…
Chromatography testing and mass spectrometry are two analytical techniques widely used in scientific research, pharmaceuticals, food safety, environmental analysis, and forensic investigations.
Chromatography testing and mass spectrometry are two analytical techniques widely used in scientific research, pharmaceuticals, food safety, environmental analysis, and forensic investigations. These techniques play a crucial role in identifying and quantifying chemical compounds, determining the purity of substances, and understanding molecular structures. In this article, we will explore the principles, applications, and benefits of chromatography testing and mass spectrometry. Chromatography Testing Chromatography is a powerful separation technique that allows scientists to separate and analyze co…
Chromatography testing and mass spectrometry are two analytical techniques widely used in scientific research, pharmaceuticals, food safety, environmental analysis, and forensic investigations. These techniques play a crucial role in identifying and quantifying chemical compounds, determining the purity of substances, and understanding molecular structures. In this article, we will explore the principles, applications, and benefits of chromatography testing and mass spectrometry. Chromatography Testing Chromatography is a powerful separation technique that allows scientists to separate and analyze co…
In drug delivery systems, marine polysaccharides can be combined with nanotechnology to improve efficacy and safety by controlling the rate, timing, and location of drug release in the body. For example, chitosan-based nanoparticles have been developed to achieve controlled release of cationic drugs, enzyme immobilization support, and encapsulation of bioactive compounds.
Source of Marine Polysaccharides Marine polysaccharides are primarily sourced from a diverse range of marine organisms that thrive in oceans and seas. Seaweeds are the primary and most abundant source of marine polysaccharides. Seaweeds with high polysaccharide content, such as red algae (Rhodophyta), brown algae (Phaeophyceae), and green algae (Chlorophyta), have been extensively studied for their polysaccharide compositi…
Source of Marine Polysaccharides Marine polysaccharides are primarily sourced from a diverse range of marine organisms that thrive in oceans and seas. Seaweeds are the primary and most abundant source of marine polysaccharides. Seaweeds with high polysaccharide content, such as red algae (Rhodophyta), brown algae (Phaeophyceae), and green algae (Chlorophyta), have been extensively studied for their polysaccharide compositi…
Conducting toxicological evaluation helps assess potential risks associated with cosmetic ingredients, ensuring consumer safety.
Cosmetics play a significant role in our daily lives, with millions of people using them to enhance their appearance or maintain their skincare routine. However, the safety of these products should always be a top priority. To ensure the safety and quality of cosmetics, thorough toxicological evaluation, and physical and chemical testing are crucial steps in the development and manufacturing process. Physical and chemical testing of cosmetics is essential to assess their quality and stability. These tests help determine the physical properties and chemical composition of the products, ensuring they meet required standards. One of the most common physical test…
Cosmetics play a significant role in our daily lives, with millions of people using them to enhance their appearance or maintain their skincare routine. However, the safety of these products should always be a top priority. To ensure the safety and quality of cosmetics, thorough toxicological evaluation, and physical and chemical testing are crucial steps in the development and manufacturing process. Physical and chemical testing of cosmetics is essential to assess their quality and stability. These tests help determine the physical properties and chemical composition of the products, ensuring they meet required standards. One of the most common physical test…
In this article, we will explore various types of microneedle patch technologies, including phase-transition microneedle patches, hydrogel microneedle patches, solid microneedles, hollow microneedles, coated microneedles, and dissolving microneedles. Each of these technologies presents unique characteristics and benefits in drug delivery applications.
Microneedle patch technologies have revolutionized the field of drug delivery, offering a wide range of advantages over traditional methods. These innovative patches provide a minimally invasive and painless alternative to injections while ensuring precise and controlled drug administration. In this article, we will explore various types of microneedle patch technologies, including phase-transition microneedle patches, hydrogel microneedl…
Microneedle patch technologies have revolutionized the field of drug delivery, offering a wide range of advantages over traditional methods. These innovative patches provide a minimally invasive and painless alternative to injections while ensuring precise and controlled drug administration. In this article, we will explore various types of microneedle patch technologies, including phase-transition microneedle patches, hydrogel microneedl…
16-Nov-2023
As with antibody detection, the most commonly used antigen detection methods are enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA).
Antigen Detection Raw Materials An antigen is a molecule (such as protein) that causes the immune system to produce antibodies and trigger an immune response. In the case of COVID-19, structural proteins were found on the surface of SARS-CoV-2 virus. Therefore, it is possible to determine whether a person is infected with virus by detecting the presence of these proteins of the SARS-CoV-2 virus. At present, the authorized antigen detection is mainly to detect the spike or nucleocapsid protein antigen of SARS-CoV-2 virus from nasal swabs or similar clinical specimens to quickly diagnose active infection. Antigen detection is usually l…
Antigen Detection Raw Materials An antigen is a molecule (such as protein) that causes the immune system to produce antibodies and trigger an immune response. In the case of COVID-19, structural proteins were found on the surface of SARS-CoV-2 virus. Therefore, it is possible to determine whether a person is infected with virus by detecting the presence of these proteins of the SARS-CoV-2 virus. At present, the authorized antigen detection is mainly to detect the spike or nucleocapsid protein antigen of SARS-CoV-2 virus from nasal swabs or similar clinical specimens to quickly diagnose active infection. Antigen detection is usually l…
16-Nov-2023
For medical devices, unique device identification (UDI) is a standard requirement. UDI provides a standardized method for identifying and tracking medical devices, offering numerous benefits for patients, healthcare professionals, and the supply chain. It improves quality standards and transforms the medical device industry.
How UDI is Improving Medical Devices The safety and reliability of medical devices is paramount. However, there are times that issues arise, causing safety and other potential concerns. To quickly and efficiently handle these situations when they arise, several practices have been implemented over the years. In 2007, Congress decided that medical devices should not face lengthy recall periods like this. It instructed the Federal Drug Administration (FDA) to…
How UDI is Improving Medical Devices The safety and reliability of medical devices is paramount. However, there are times that issues arise, causing safety and other potential concerns. To quickly and efficiently handle these situations when they arise, several practices have been implemented over the years. In 2007, Congress decided that medical devices should not face lengthy recall periods like this. It instructed the Federal Drug Administration (FDA) to…
In the ever-evolving digital landscape, your frontend is your first and lasting impression. A user-friendly, responsive, and well-maintained frontend is the cornerstone of a successful online presence. Investing in a top-notch frontend web development company, like Appstudio, ensures that your digital storefront is not just open for business but is also welcoming, efficient, and ready to impress.
Did you know that 88% of users are less likely to return to a website after a bad user experience? In the digital realm, where first impressions are everything, the frontend of your website plays a pivotal role. A seamless and visually appealing frontend isn't just eye candy; it's a silent persuader, guiding users through a delightful digital journey. Crafting User-Friendly Interfaces: The Essence…
Did you know that 88% of users are less likely to return to a website after a bad user experience? In the digital realm, where first impressions are everything, the frontend of your website plays a pivotal role. A seamless and visually appealing frontend isn't just eye candy; it's a silent persuader, guiding users through a delightful digital journey. Crafting User-Friendly Interfaces: The Essence…
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24.
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24. In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems. We highlight the differences between key markets and provide a high-level guide for…
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24. In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems. We highlight the differences between key markets and provide a high-level guide for…
Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it means for Pharma and Medical Device manufacturers launching new technologies from 2025.
What is the EU JCA? In January 2022, the European Parliament enacted a new EU Health Technology Assessment (HTA) Regulation, with the aim of standardising clinical assessment of medicines and high-risk medical devices across the EU and avoiding duplication of work. Currently, Pharma and Medtech manufacturers have to submit evidence individually in each of the 27 EU markets; the intention of the JCA is that at least some of the assessment can be done centrally. The JCA report will act as a universal information source for relative treatment effects, safety…
What is the EU JCA? In January 2022, the European Parliament enacted a new EU Health Technology Assessment (HTA) Regulation, with the aim of standardising clinical assessment of medicines and high-risk medical devices across the EU and avoiding duplication of work. Currently, Pharma and Medtech manufacturers have to submit evidence individually in each of the 27 EU markets; the intention of the JCA is that at least some of the assessment can be done centrally. The JCA report will act as a universal information source for relative treatment effects, safety…
10-Nov-2023
Broughton expands analytical testing services with a one-stop solution for Extractables and Leachables
To help pharmaceutical and consumer healthcare companies bring their products to market safely and efficiently, scientific consultancy and contract research organization (CRO) Broughton has launched a new Extractables and Leachables (E&L) testing service. Regulatory bodies increasingly focus on the interactions between manufacturing components, drug delivery devices and container-closure systems (CCS), and the final product formulation. Producers must identify and assess any toxicological risks that could arise via such interactions. Broughton’s new service will offer tailored E&L studies with a fully integrated approach that combines technical and analytical services, in-house to…
To help pharmaceutical and consumer healthcare companies bring their products to market safely and efficiently, scientific consultancy and contract research organization (CRO) Broughton has launched a new Extractables and Leachables (E&L) testing service. Regulatory bodies increasingly focus on the interactions between manufacturing components, drug delivery devices and container-closure systems (CCS), and the final product formulation. Producers must identify and assess any toxicological risks that could arise via such interactions. Broughton’s new service will offer tailored E&L studies with a fully integrated approach that combines technical and analytical services, in-house to…
Clinion has secured the top spot on the list of Clinical Trial Management Solutions for the year 2023
Austin, TX — November 08, 2023 Clinion is Named as The Top Clinical Trial Management Solution Provider of 2023 by Medhealth Review We are proud to announce that Clinion has secured the top spot on the list of Clinical Trial Management Solutions for the year 2023. This remarkable recognition underscores our commitment to transforming the landscape of clinical trials with cutting-edge AI-enabled technology. At Clinion, we’ve always aimed for excellence, and this achievement is a testament to our dedication to providing innovative solutions that streamline and enhance the entire clinical trial process. Our fully integrated eClinical software platform, equipped with EDC, IWRS/RTSM, CTMS, ePRO,…
Austin, TX — November 08, 2023 Clinion is Named as The Top Clinical Trial Management Solution Provider of 2023 by Medhealth Review We are proud to announce that Clinion has secured the top spot on the list of Clinical Trial Management Solutions for the year 2023. This remarkable recognition underscores our commitment to transforming the landscape of clinical trials with cutting-edge AI-enabled technology. At Clinion, we’ve always aimed for excellence, and this achievement is a testament to our dedication to providing innovative solutions that streamline and enhance the entire clinical trial process. Our fully integrated eClinical software platform, equipped with EDC, IWRS/RTSM, CTMS, ePRO,…
In the realm of healthcare, the pervasive use of medical device coating has undeniably propelled advancements, enhancing the efficacy and functionality of critical instruments. Yet, this progress is not without consequence, as the environmental impact of these coatings looms large.
As of 2023, the global medical device coatings market stands at an estimated USD 7.7 billion, poised for a continuous upward trajectory at a compounded annual growth rate (CAGR) of 7.7%. The World Health Organization (WHO) reports an astounding two million medical devices globally, underlining the ubiquity of these coatings in modern healthcare. Against this backdrop, the imperative for environmental sustainability in medical device coating becomes paramount. The conundrum lies in balancing the relentless pursui…
As of 2023, the global medical device coatings market stands at an estimated USD 7.7 billion, poised for a continuous upward trajectory at a compounded annual growth rate (CAGR) of 7.7%. The World Health Organization (WHO) reports an astounding two million medical devices globally, underlining the ubiquity of these coatings in modern healthcare. Against this backdrop, the imperative for environmental sustainability in medical device coating becomes paramount. The conundrum lies in balancing the relentless pursui…
In the dynamic realm of pharmaceutical innovation, DNA Encoded Libraries (DELs) have emerged as a transformative force, reshaping the landscape of drug discovery.
With the global DNA encoded library market estimated at USD 840 million in 2023 and a projected compound annual growth rate (CAGR) of 16%, their significance cannot be overstated, DELs, integrating cutting-edge technologies from X-Chem, Haystack Sciences, and ZebiAI, are revolutionizing hit identification and lead optimization. Pioneering companies like Relay Therapeutics exemplify the tangible impact of DELs in targeting proteins linked to conditions such as cystic fibrosis and lung diseases. As Pharma leaders navigate the intricate terrain of DNA sequencing, chemical libraries, and machine learning, this guide illuminates the s…
With the global DNA encoded library market estimated at USD 840 million in 2023 and a projected compound annual growth rate (CAGR) of 16%, their significance cannot be overstated, DELs, integrating cutting-edge technologies from X-Chem, Haystack Sciences, and ZebiAI, are revolutionizing hit identification and lead optimization. Pioneering companies like Relay Therapeutics exemplify the tangible impact of DELs in targeting proteins linked to conditions such as cystic fibrosis and lung diseases. As Pharma leaders navigate the intricate terrain of DNA sequencing, chemical libraries, and machine learning, this guide illuminates the s…
82% of employers rate employee referrals above all other sources for generating the best ROI, with employers saving an average of 13 days and $1,000+ in recruiting costs when hiring a referral. The benefits of an effective ERP go above and beyond financial and time-saving advantages to include things such as improved retention, engagement, productivity, and commitment from employees, helping your workforce thrive.
As a recruitment professional in the life science industry, employee referral programs (ERPs) are a highly effective way of expanding your talent pool, identifying high-quality candidates, and engaging both active and passive talent. 82% of employers rate employee referrals above all other sources for generating the best ROI, with employers saving an average of 13 days and $1,000+…
As a recruitment professional in the life science industry, employee referral programs (ERPs) are a highly effective way of expanding your talent pool, identifying high-quality candidates, and engaging both active and passive talent. 82% of employers rate employee referrals above all other sources for generating the best ROI, with employers saving an average of 13 days and $1,000+…
Omega-3 fatty acids are crucial in proper body functioning. Its main three forms are docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and eicosapentaenoic acid (EPA).1 Several studies have proved the positive impact of this nutrient on heart and brain health, yet the latest one takes a new spin on auditory health.
Omega-3 fatty acids are crucial in proper body functioning. Its main three forms are docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and eicosapentaenoic acid (EPA).1 Several studies have proved the positive impact of this nutrient on heart and brain health, yet the latest one takes a new spin on auditory health. A recent study dove into the potential benefits of one type of omega-3 fatty acid in hearing functions, citing DHA levels are inversely correlated with aud…
Omega-3 fatty acids are crucial in proper body functioning. Its main three forms are docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and eicosapentaenoic acid (EPA).1 Several studies have proved the positive impact of this nutrient on heart and brain health, yet the latest one takes a new spin on auditory health. A recent study dove into the potential benefits of one type of omega-3 fatty acid in hearing functions, citing DHA levels are inversely correlated with aud…
02-Nov-2023
The 18th Project Portfolio and Resource Management Excellence Conference, set for February 13-15, 2024 in Northern New Jersey, is a crucial event for industry leaders. The conference focuses on optimizing resource management, aligning project strategies, navigating market pressures, and embracing innovation. With a lineup of industry experts and insightful sessions, attendees can expect to gain actionable strategies and valuable connections.
Northern New Jersey, February 13-15, 2024 In an ever-evolving pharmaceutical and biotechnology landscape, effective portfolio and project management are paramount. The 18th Project Portfolio and Resource Management Excellence Conference, set to take place in Northern New Jersey from February 13th to 15th, 2024, promises to be a crucible of insights and…
Northern New Jersey, February 13-15, 2024 In an ever-evolving pharmaceutical and biotechnology landscape, effective portfolio and project management are paramount. The 18th Project Portfolio and Resource Management Excellence Conference, set to take place in Northern New Jersey from February 13th to 15th, 2024, promises to be a crucible of insights and…
There is no doubt that Generative AI will transform IT delivery. Dirk Bode, CEO of fme, recommends optimising core business strategy and identifying where Generative AI could be harnessed to support the strategy.
AI, and specifically Generative AI, is going to transform IT delivery as well as a whole host of other corporate functions. Via secure company-wide intranets that draw on open, cloud-based AI platforms, to intelligent bot-enabled business functions and regulatory processes, ChatGPT and tools like it are going to transform the way entire organisations access, collate and distribute knowledge, and create new assets – as well as what they do with all of it. Very soon (if they aren’t already piloting projects) companies will first scrutinise and clean up, then migrate content to a sec…
AI, and specifically Generative AI, is going to transform IT delivery as well as a whole host of other corporate functions. Via secure company-wide intranets that draw on open, cloud-based AI platforms, to intelligent bot-enabled business functions and regulatory processes, ChatGPT and tools like it are going to transform the way entire organisations access, collate and distribute knowledge, and create new assets – as well as what they do with all of it. Very soon (if they aren’t already piloting projects) companies will first scrutinise and clean up, then migrate content to a sec…
In this article, we highlight some of the top associations dedicated to regulatory affairs for you to explore. These associations have a proven track record of providing exceptional opportunities for regulatory affairs professionals, and of working collaboratively with members to advocate for excellence in the field.
As a regulatory affairs professional, you’ll know how challenging it can be to navigate complex regulations and ensure compliance. To excel in this dynamic field and advance your career, you could benefit greatly from joining a reputable professional association dedicated to regulatory affairs, opening you up to endless networking and learning and development opportunities. In this article, we highlight some of the top associations dedicated to regulatory affairs for you to exp…
As a regulatory affairs professional, you’ll know how challenging it can be to navigate complex regulations and ensure compliance. To excel in this dynamic field and advance your career, you could benefit greatly from joining a reputable professional association dedicated to regulatory affairs, opening you up to endless networking and learning and development opportunities. In this article, we highlight some of the top associations dedicated to regulatory affairs for you to exp…
